These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Pulmonary fibrosis in sarcoidosis. Clinical features and outcomes. Patterson KC; Strek ME Ann Am Thorac Soc; 2013 Aug; 10(4):362-70. PubMed ID: 23952859 [TBL] [Abstract][Full Text] [Related]
11. [Computed tomography in evaluating the development of different types of pulmonary fibrosis in patients with interstitial lung diseases]. Speranskaya AA; Novikova LN; Baranova OP; Dvorakovskaya IV; Kameneva MY; Amosova NA Vestn Rentgenol Radiol; 2015; (4):5-11. PubMed ID: 26552223 [TBL] [Abstract][Full Text] [Related]
12. The extended utility of antifibrotic therapy in progressive fibrosing interstitial lung disease. Sarkar P; Avram C; Chaudhuri N Expert Rev Respir Med; 2020 Oct; 14(10):1001-1008. PubMed ID: 32567402 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary sarcoidosis complicated by rheumatoid arthritis in a patient presenting with progressive fibrosing interstitial lung disease and treated with nintedanib: a case report and literature review. Suzuki A; Kamio K; Takeno M; Terasaki Y; Taniuchi N; Sato J; Nishijima N; Saito Y; Seike M; Gemma A; Azuma A Ther Adv Respir Dis; 2023; 17():17534666231158279. PubMed ID: 36872912 [TBL] [Abstract][Full Text] [Related]
14. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib. Makino S Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766 [TBL] [Abstract][Full Text] [Related]